Author
Listed:
- Francisco J. Sánchez-Rivera
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Massachusetts Institute of Technology)
- Thales Papagiannakopoulos
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Rodrigo Romero
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Massachusetts Institute of Technology)
- Tuomas Tammela
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Matthew R. Bauer
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Arjun Bhutkar
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Nikhil S. Joshi
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Lakshmipriya Subbaraj
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Roderick T. Bronson
(Tufts University
Harvard Medical School)
- Wen Xue
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Tyler Jacks
(David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Massachusetts Institute of Technology
Howard Hughes Medical Institute, Massachusetts Institute of Technology)
Abstract
The CRISPR/Cas system has been used in mice for genome editing to introduce genetic alterations found in human lung tumours, and these genome modifications resulted in mouse lung tumours showing different histopathologies depending on the genes altered; the CRISPR/Cas system offers improved and faster ways to create animal models of human diseases such as cancer.
Suggested Citation
Francisco J. Sánchez-Rivera & Thales Papagiannakopoulos & Rodrigo Romero & Tuomas Tammela & Matthew R. Bauer & Arjun Bhutkar & Nikhil S. Joshi & Lakshmipriya Subbaraj & Roderick T. Bronson & Wen Xue &, 2014.
"Rapid modelling of cooperating genetic events in cancer through somatic genome editing,"
Nature, Nature, vol. 516(7531), pages 428-431, December.
Handle:
RePEc:nat:nature:v:516:y:2014:i:7531:d:10.1038_nature13906
DOI: 10.1038/nature13906
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:516:y:2014:i:7531:d:10.1038_nature13906. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.